EMA Authorised: Zoledronic acid medac (zoledronic acid monohydrate) — medac Gesellschaft für klinische Spezialpräparate mbH

View source ↗

Summary

The EMA authorised zoledronic acid monohydrate (Zoledronic acid medac) for use in fractures/bone-related conditions and cancer, under the marketing authorisatio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bone Fractures
• Bone Metastases
• Cancer-related Bone Disease

Drugs mentioned

• Zoledronic acid medac (zoledronic acid monohydrate)

Snippet

Status: Authorised. Therapeutic area: Fractures, Bone;Cancer. MAH: medac Gesellschaft für klinische Spezialpräparate mbH. Decision date: 23/09/2020